Neoplasia and hormonal contraception.
D000818:Animals; D001941:Breast Diseases / Q000139:chemically induced; D001943:Breast Neoplasms / Q000139:chemically induced; D002822:Choriocarcinoma / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003279:Contraceptives, Oral, Sequential / Q000009:adverse effects; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D004714:Endometrial Hyperplasia / Q000139:chemically induced; D004812:Epidemiologic Methods; D045166:Estradiol Congeners / Q000009:adverse effects; D004964:Estriol / Q000009:adverse effects; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced; D009369:Neoplasms / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000139:chemically induced; D010911:Pituitary Neoplasms / Q000139:chemically induced; D011247:Pregnancy; D045167:Progesterone Congeners / Q000009:adverse effects; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D003276:Contraceptives, Oral; D003279:Contraceptives, Oral, Sequential; D003280:Contraceptives, Oral, Synthetic; D045166:Estradiol Congeners; D045167:Progesterone Congeners; D004964:Estriol